JOHN ZAZAIAN: Open Payments
NPI 1871581934 · WATERFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 12 payments from 7 companies in 2025. Trend: 2023 $101 · 2024 $121 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| ABBVIE INC. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Exact Sciences Corporation | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Solventum Corporation | 1 | $15 |
Products named: FARXIGA, QULIPTA, BREZTRI, TRELEGY ELLIPTA, Cologuard Collection Kit, ELIQUIS, ACTIV.A.C..
Industry payments across MI — which companies pay providers there.
